Skip to main content
Erschienen in: Journal of General Internal Medicine 1/2020

06.08.2019

The Role of Screening in Depression Diagnosis and Treatment in a Representative Sample of US Primary Care Visits

verfasst von: Hillary Samples, PhD, MHS, Elizabeth A. Stuart, PhD, Brendan Saloner, PhD, Colleen L. Barry, PhD MPP, Ramin Mojtabai, MD, PhD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary care providers encounter a large proportion of the population with depression. Yet, many primary care patients with depression remain undiagnosed and untreated.

Objective

This study aims to examine depression screening patterns and the role of screening in depression diagnosis and treatment in the outpatient primary care setting.

Design

This is a cross-sectional analysis of nationally representative survey data of visits to outpatient physician offices from the 2005 to 2015 National Ambulatory Medical Care Surveys.

Participants

The sample included the first visit in the past year to a primary care provider by patients 12 years and older (N = 16,887).

Methods

The associations of visit characteristics with depression screening and of depression screening with depression diagnosis and treatment during the visit were assessed using logistic regression. Logistic regression with propensity score weighting was used to estimate the odds of depression diagnosis and treatment under the counterfactual scenario in which patients who visited providers with lower depression screening rates had visited providers with higher screening rates instead. All models were adjusted for patient and visit characteristics.

Key Results

A small proportion of sample visits involved depression screening (3.0%). Visits by patients with depressive symptom complaints were associated with higher odds of depression screening than other visits. When visits were weighted to have similar demographic and clinical characteristics, visits to providers with higher screening rates had higher odds of diagnosis (OR = 1.99, p < 0.001) and treatment (OR = 1.61, p = 0.001) compared to visits to providers with lower screening rates.

Conclusions

Physicians appear to use depression screening selectively based on patients’ presenting symptoms. Higher screening rates were associated with higher odds of depression diagnosis and treatment, and even modest increases in screening rates could meaningfully increase population-level rates of depression identification and treatment in primary care. Future research is needed to identify barriers to depression care and implement systematic interventions to improve services and patient outcomes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Rushton JL, Felt BT, Roberts MW. Coding of pediatric behavioral and mental disorders. Pediatrics. 2002;110(1).CrossRefPubMed Rushton JL, Felt BT, Roberts MW. Coding of pediatric behavioral and mental disorders. Pediatrics. 2002;110(1).CrossRefPubMed
9.
Zurück zum Zitat Rost K, Smith GR, Matthews DB, Guise B. The deliberate misdiagnosis of major depression in primary care. Arch Fam Med 1994;3:333–337.CrossRefPubMed Rost K, Smith GR, Matthews DB, Guise B. The deliberate misdiagnosis of major depression in primary care. Arch Fam Med 1994;3:333–337.CrossRefPubMed
10.
Zurück zum Zitat American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th Ed., Text Revision. 4th edn. Arlington: American Psychiatric Association; 2000. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th Ed., Text Revision. 4th edn. Arlington: American Psychiatric Association; 2000.
11.
Zurück zum Zitat American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th Ed. 5th ed. Arlington: American Psychiatric Association; 2013. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th Ed. 5th ed. Arlington: American Psychiatric Association; 2013.
15.
Zurück zum Zitat O’Connor E, Rossom RC, Henninger M, et al. Screening for Depression in Adults: An Updated Systematic Evidence Review for The U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality; 2015. O’Connor E, Rossom RC, Henninger M, et al. Screening for Depression in Adults: An Updated Systematic Evidence Review for The U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality; 2015.
17.
18.
Zurück zum Zitat U.S. Preventive Services Task Force. Screening for depression in adults: U.S. Preventive Services Task Force recommentaion statement. Ann Intern Med. 2009;151(11):785–792. U.S. Preventive Services Task Force. Screening for depression in adults: U.S. Preventive Services Task Force recommentaion statement. Ann Intern Med. 2009;151(11):785–792.
20.
Zurück zum Zitat World Health Organization. International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Geneva: World Health Organization; 2008. World Health Organization. International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Geneva: World Health Organization; 2008.
22.
Zurück zum Zitat StataCorp. Stata Statistical Software: Release 15. 2017. StataCorp. Stata Statistical Software: Release 15. 2017.
25.
Zurück zum Zitat McGoey ST, Huang KE, Palmes GK. Low depression screening rates in U.S. ambulatory care. Psychiatr Serv. 2013;64(10):1068.CrossRefPubMed McGoey ST, Huang KE, Palmes GK. Low depression screening rates in U.S. ambulatory care. Psychiatr Serv. 2013;64(10):1068.CrossRefPubMed
26.
Zurück zum Zitat Schmitt MR, Miller MJ, Harrison DL, Touchet BK. Relationship of depression screening and physician office visit duration in a national sample. Psychiatr Serv 2010;61(11):1126–1131.CrossRefPubMed Schmitt MR, Miller MJ, Harrison DL, Touchet BK. Relationship of depression screening and physician office visit duration in a national sample. Psychiatr Serv 2010;61(11):1126–1131.CrossRefPubMed
28.
Zurück zum Zitat Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression: systematic evidence review. 2002. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression: systematic evidence review. 2002.
29.
Zurück zum Zitat Forman-Hoffman V, McClure E, McKeeman J, et al. Screening for Major Depressive Disorder Among Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality; 2016. Forman-Hoffman V, McClure E, McKeeman J, et al. Screening for Major Depressive Disorder Among Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality; 2016.
36.
Zurück zum Zitat Trangle M, Gursky J, Haight R, et al. Health care guideline: depression in primary care. 2016. Trangle M, Gursky J, Haight R, et al. Health care guideline: depression in primary care. 2016.
Metadaten
Titel
The Role of Screening in Depression Diagnosis and Treatment in a Representative Sample of US Primary Care Visits
verfasst von
Hillary Samples, PhD, MHS
Elizabeth A. Stuart, PhD
Brendan Saloner, PhD
Colleen L. Barry, PhD MPP
Ramin Mojtabai, MD, PhD, MPH
Publikationsdatum
06.08.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 1/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05192-3

Weitere Artikel der Ausgabe 1/2020

Journal of General Internal Medicine 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.